CAM
IONS icon

Costello Asset Management’s Ionis Pharmaceuticals IONS Stock Holding History

Costello Asset Management’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1
Closed – – 240
2021
Q1 		$0 Buy
+1
New +$56 ﹤0.01% 259

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Costello Asset Management's IONS Position: Q2 2021 in Review

Costello Asset Management sold out of Ionis Pharmaceuticals (IONS) in Q2 2021, closing a stake of 1 share.

Costello Asset Management first reported a position in IONS in Q1 2021 and held it in 1 quarter. The position peaked at $0 in Q1 2021. 337 funds tracked by Wall St. Rank hold IONS as of Q2 2021.

  • Costello Asset Management reported no remaining Ionis Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • Costello Asset Management sold 1 Ionis Pharmaceuticals share in Q2 2021.
  • Costello Asset Management first reported a position in Ionis Pharmaceuticals in Q1 2021 and held it in 1 quarter.
  • Costello Asset Management's Ionis Pharmaceuticals position peaked at $0 in Q1 2021.
  • 337 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2021.

Based on Costello Asset Management's 13F filing for Q2 2021, filed 5 Aug 2021.